Abstract
At a Glance
Tissue biopsies serve a valuable purpose – but they are far from perfect
Liquid biopsy may be a better option, if we can overcome its technical limitations
Ovarian cancer is one disease that can benefit from better biomarkers and better assays
Epigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
Tissue biopsies serve a valuable purpose – but they are far from perfect
Liquid biopsy may be a better option, if we can overcome its technical limitations
Ovarian cancer is one disease that can benefit from better biomarkers and better assays
Epigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
| Original language | English |
|---|---|
| Publisher | The Pathologist |
| Publication status | Published - 02 Jan 2019 |
Access to Document
Fingerprint
Dive into the research topics of 'The Evolution of Epigenetic Biomarkers: Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers'. Together they form a unique fingerprint.Student theses
-
The development of a blood-based test of DNA methylation for the earlier detection of high-grade serous tubo-ovarian cancer
Feeney, L. (Author), Mullan, P. (Supervisor), Salto-Tellez, M. (Supervisor) & Beirne, J. P. (Supervisor), Jul 2020Student thesis: Doctoral Thesis › Doctor of Philosophy